Rekombinanter KRT20 Antikörper (AA 196-323)
Kurzübersicht für Rekombinanter KRT20 Antikörper (AA 196-323) (ABIN7871715)
Target
Alle KRT20 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 196-323
-
Verwendungszweck
- Recombinant CK20 Antibody / Cytokeratin 20
-
Aufreinigung
- Protein A affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 196-323) was used as the immunogen for this Cytokeratin 20 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant CK20 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- KRT20 (Keratin 20 (KRT20))
-
Andere Bezeichnung
- CK20
-
Hintergrund
- This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
-
UniProt
- P35900
Target
-